Subscribe and Stay Informed
Receive industry-leading content from our experts
Start exploring
New Paper Makes the Case for AI-Specific Guidance in Research Oversight
Estimated reading time: 3 minutes AI is becoming a routine part of how research proposals…
Q&A with Senior Manager of Client Services Francine Lopez
Estimated reading time: 3 minutes For nearly a decade, Francine Lopez has helped clinical research…
Rethinking Oncology Trial Design: Turning Insights from Data and Experience into More Feasible Studies
Estimated reading time: 4 minutes Oncology research continues to push scientific boundaries, from biomarker-driven therapies…
Insights on the FDA’s ELSA AI And What Changes Next
Traditional clinical trial designs often delay progress due to rigid protocols and frequent amendments. Adaptive…
Preparing for Elsa: What Sponsors, Sites, and CROs Need to Know About the FDA’s New AI Era
Traditional clinical trial designs often delay progress due to rigid protocols and frequent amendments. Adaptive…
Simplifying Oversight and Managing Regulatory Complexity in Multi-Site Clinical Trials
Traditional clinical trial designs often delay progress due to rigid protocols and frequent amendments. Adaptive…